Director, Professor Ian Wilkinson
Cambridge Clinical Trials Unit
We are a science-led NIHR UKCRC registered academic clinical trials unit with a diverse portfolio of interventional trials, covering a broad spectrum of treatment areas. We work with researchers from CUHP and the broader research network of CUHP to deliver high quality clinical research, to inform improvements in healthcare delivery across the United Kingdom and globally.
Clinical Trials in a Nut Shell
The CCTU is part of the NIHR Cambridge BRC, which works with scientists to ensure that their discoveries are pulled into the NHS to improve health. The NIHR Cambridge BRC established the NIHR BioResource for Translational Research in Common and Rare Diseases, building on the success of the NIHR BioResource-Rare Diseases Translational Research Collaboration.
Research is central to CUH’s identity as a leading NHS hospital and development as an academic research centre. Cambridge is home to one of the richest pools of clinical and scientific knowledge and expertise in the world. At CUH doctors and scientists collaborate across disciplines and specialties and it is this co-existence of experience and expertise that fosters translational research.
The CCTU is a founding member of the International Clinical Trial Centre Network which aims to improve clinical research by fostering collaborations worldwide to form a unique network of leading trial centres with a global reach, promoting and facilitating the efficient conduct of clinical trials across the world. More
Established in 2015 by members of the CCTU, the PLRH provides academic expertise in all aspects of research design and conduct free from a defined research agenda. We aim to collaborate with as many external experts as possible, spanning medicine, academia, research and industry. More
A tool to prepare the required statistics needed by the European Clinical Trials Database and format them into the precise requirements, to directly upload an XML file into the database with no further data entry by hand.